Varicella-zoster virus infections of the central nervous system - Prognosis, diagnostics and treatment

Journal of Infection

Volumn 71, Issue 3, 2015, Pages 281-293

  Grahn, Anna ^a,b   Studahl, Marie ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Central nervous system infections; Diagnostics; Encephalitis; Prognosis; Treatment; Varicella zoster virus

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; CHICKENPOX VACCINE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; STEROID; VALACICLOVIR; VARICELLA ZOSTER VACCINE; VIRUS DNA; HERPES VACCINE;

ANTIBODY PRODUCTION; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM INFECTION; CEREBELLITIS; CEREBELLUM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE PARALYSIS; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES ZOSTER; HERPES ZOSTER OTICUS; HUMAN; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; INCIDENCE; KIDNEY DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MENINGITIS; MORBIDITY; MORTALITY; MYELITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PSYCHOPATHY; REVIEW; REYE SYNDROME; SYMPTOMATOLOGY; TREATMENT RESPONSE; VACCINATION; VASCULAR DISEASE; VASCULITIS; VIRUS DETECTION; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHICKENPOX; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; MALE; VIROLOGY;

CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHICKENPOX; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; HERPES ZOSTER; HERPESVIRUS VACCINES; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; VASCULITIS;

EID: 84942833730     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.06.004     Document Type: Review

References (136)

1. Bergstrom T. Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations. Scand J Infect Dis Suppl 1996;100:41-5
2. Koskiniemi M, Piiparinen H, Rantalaiho T, Eranko P, Farkkila M, Raiha K, et al. Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 2002;25(3):293-301
3. Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008;70(11):853-60
4. Persson A, Bergstrom T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS diseaseeviral load, clinical manifestations and sequels. J Clin Virol 2009;46(3):249-53 http://dx.doi.org/10.1016/j.jcv.2009.07.014.
5. De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JPSteering Committee and Investigators Group. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 2012;18(8):808-19 http://dx.doi.org/10.1111/j.1469-0691.2011.03705.x.
6. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al Group UKHPAAoES. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010;10(12):835-44 http://dx.doi.org/10.1016/S1473-3099(10)70222-X.
7. Mailles A, De Broucker T, Costanzo P, Martinez-Almoyna L, Vaillant V, Stahl JP, et al. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis 2012;54(10):1455-64 http://dx.doi.org/10.1093/cid/cis226.
8. Ratzka P, Schlachetzki JC, Bahr M, Nau R. Varicella zoster virus cerebellitis in a 66-year-old patient without herpes zoster. Lancet 2006;367(9505):182. http://dx.doi.org/10.1016/S0140-6736(06)67967-1.
9. Science M, MacGregor D, Richardson SE, Mahant S, Tran D, Bitnun A. Central nervous system complications of varicellazoster virus. J Pediatr 2014;165(4):779-85 http://dx.doi.org/10.1016/j.jpeds.2014.06.014.
10. Liu GT, Urion DK. Pre-eruptive varicella encephalitis and cerebellar ataxia. Pediatr Neurol 1992;8(1):69-70
11. Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH. The patterns of varicella zoster virus encephalitis. Hum Pathol 1996;27(9):927-38
12. Chretien F, Gray F, Lescs MC, Geny C, Dubreuil-Lemaire ML, Ricolfi F, et al. Acute varicella-zoster virus ventriculitis and meningo-myelo-radiculitis in acquired immunodeficiency syndrome. Acta Neuropathol 1993;86(6):659-65
13. Gray F, Belec L, Lescs MC, Chretien F, Ciardi A, Hassine D, et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994;117(Pt 5):987-99
14. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342(9):635-45
15. Jaenson TG, Hjertqvist M, Bergstrom T, Lundkvist A. Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Parasites Vectors 2012;5:184. http://dx.doi.org/10.1186/1756-3305-5-184.
16. Mendoza LP, Bronzoni RV, Takayanagui OM, Aquino VH, Figueiredo LT. Viral infections of the central nervous system in Brazil. J Infect 2007;54(6):589-96 http://dx.doi.org/10.1016/j.jinf.2006.11.013.
17. de Ory F, Avellon A, Echevarria JE, Sanchez-Seco MP, Trallero G, Cabrerizo M, et al. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol 2013;85(3):554-62 http://dx.doi.org/10.1002/jmv.23470.
18. Kleines M, Scheithauer S, Schiefer J, Hausler M. Clinical application of viral cerebrospinal fluid PCR testing for diagnosis of central nervous system disorders: a retrospective 11-year experience. Diagn Microbiol Infect Dis 2014;80(3):207-15 http://dx.doi.org/10.1016/j.diagmicrobio.2014.07.010.
19. Frenos S, Galli L, Chiappini E, de Martino M. An increasing incidence of chickenpox central nervous system complications in children: what's happening in Tuscany? J Clin Virol 2007;38(4):358-61
20. Rack AL, Grote V, Streng A, Belohradsky BH, Heinen F, von Kries R, et al. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol 2010; 42(1):40-8 http://dx.doi.org/10.1016/j.pediatrneurol.2009.07.012.
21. Guess HA, Broughton DD, Melton 3rd LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics 1986;78(4 Pt 2):723-7
22. Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 2007;92(12):1062-6 http://dx.doi.org/10.1136/adc.2007.123232.
23. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 2001;108(5):E79.
24. Bonhoeffer J, Baer G, Muehleisen B, Aebi C, Nadal D, Schaad UB, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 2005;164(6):366-70 http://dx.doi.org/10.1007/s00431-005-1637-8.
25. Marchetto S, de Benedictis FM, de Martino M, Versace A, Chiappini E, Bertaine C, et al. Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era. Acta Paediatr 2007; 96(10):1490-3 http://dx.doi.org/10.1111/j.1651-2227.2007.00465.x.
26. Appelbaum E, Rachelson MH, Dolgopol VB. Varicella encephalitis. Am J Med 1953;15(2):223-30
27. Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol 1994;35(6): 673-9
28. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. J Am Med Assoc 2002;287(5):606-11
29. Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, et al. Varicella in infants after implementation of the US varicella vaccination program. Pediatrics 2011; 128(6):1071-7 http://dx.doi.org/10.1542/peds.2011-0017.
30. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an Adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015;372(22): 2087-96 http://dx.doi.org/10.1056/NEJMoa1501184.
31. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352(22):2271-84
32. Mailles A, Stahl JP, Steering C, Investigators G. Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis 2009;49(12):1838-47 http://dx.doi.org/10.1086/648419.
33. Pollak L, Dovrat S, Book M, Mendelson E, Weinberger M. Varicella zoster vs. herpes simplex meningoencephalitis in the PCR era. A single center study. J Neurol Sci 2012;314(1e2): 29-36 http://dx.doi.org/10.1016/j.jns.2011.11.004.
34. Grahn A, Hagberg L, Nilsson S, Blennow K, Zetterberg H, Studahl M. Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections. J Neurol 2013;260(7): 1813-21 http://dx.doi.org/10.1007/s00415-013-6883-5.
35. Grahn A, Nilsson S, Nordlund A, Linden T, Studahl M. Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study. J Neurol 2013;260(11):2761-9 http://dx.doi.org/10.1007/s00415-013-7057-1.
36. Appelbaum E, Kreps SI, Sunshine A. Herpes zoster encephalitis. Am J Med 1962;32:25-31
37. Hokkanen L, Launes J, Poutiainen E, Valanne L, Salonen O, Siren J, et al. Subcortical type cognitive impairment in herpes zoster encephalitis. J Neurol 1997;244(4):239-45
38. Wetzel K, Asholt I, Herrmann E, Kratzer C, Masuhr F, Schielke E. Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study. J Neurol 2002; 249(11):1612-4
39. Koskiniemi M, Rantalaiho T, Piiparinen H, von Bonsdorff CH, Farkkila M, Jarvinen A, et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol 2001;7(5):400-8 http://dx.doi.org/10.1080/135502801753170255.
40. Vial C, Pozzetto B, Essid A, Stephan JL, Chabrier S. Acute encephalitis: report on 32 consecutive pediatric cases observed in one hospital. Med Maladies Infect 2007;37(4):208-14 http://dx.doi.org/10.1016/j.medmal.2007.01.008.
41. Franzen-Rohl E, Tiveljung-Lindell A, Grillner L, Aurelius E. Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples. J Clin Microbiol 2007;45(8):2516-20 http://dx.doi.org/10.1128/JCM.00141-07.
42. Hausfater P, Fillet AM, Rozenberg F, Arthaud M, Trystram D, Huraux JM, et al. Prevalence of viral infection markers by polymerase chain reaction amplification and interferon-alpha measurements among patients undergoing lumbar puncture in an emergency department. J Med Virol 2004;73(1): 137-46 http://dx.doi.org/10.1002/jmv.20068.
43. Aberle SW, Aberle JH, Steininger C, Puchhammer-Stockl E. Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol 2005;194(1e2):7-12
44. Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 2011; 203(3):316-23 http://dx.doi.org/10.1093/infdis/jiq066.
45. Gilden D. Varicella zoster virus and central nervous system syndromes. Herpes 2004;11(Suppl 2):89Ae94A.
46. Grose C, Bonthius D, Afifi AK. Chickenpox and the geniculate ganglion: facial nerve palsy, Ramsay Hunt syndrome and acyclovir treatment. Pediatr Infect Dis J 2002;21(7): 615-7
47. Kinishi M, Amatsu M, Mohri M, Saito M, Hasegawa T, Hasegawa S. Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome. Auris Nasus Larynx 2001; 28(3):223-6
48. Murakami S, Hato N, Horiuchi J, Honda N, Gyo K, Yanagihara N. Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol 1997;41(3):353-7 http://dx.doi.org/10.1002/ana.410410310.
49. Uri N, Greenberg E, Kitzes-Cohen R, Doweck I. Acyclovir in the treatment of Ramsay Hunt syndrome. Otolaryngol Head Neck Surg 2003;129(4):379-81
50. Devriese PP, Moesker WH. The natural history of facial paralysis in herpes zoster. Clin Otolaryngol Allied Sci 1988;13(4): 289-98
51. Murakami S, Nakashiro Y, Mizobuchi M, Hato N, Honda N, Gyo K. Varicella-zoster virus distribution in Ramsay Hunt syndrome revealed by polymerase chain reaction. Acta Otolaryngol 1998;118(2):145-9
52. Uscategui T, Doree C, Chamberlain IJ, Burton MJ. Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Database Syst Rev 2008. http://dx.doi.org/10.1002/14651858.CD006851.pub2(4):CD006851.
53. Uscategui T, Doree C, Chamberlain IJ, Burton MJ. Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Database Syst Rev 2008. http://dx.doi.org/10.1002/14651858.CD006852.pub2(3):CD006852.
54. Bozzola E, Tozzi AE, Bozzola M, Krzysztofiak A, Valentini D, Grandin A, et al. Neurological complications of varicella in childhood: case series and a systematic review of the literature. Vaccine 2012;30(39):5785-90 http://dx.doi.org/10.1016/j.vaccine.2012.05.057.
55. Bozzola E, Bozzola M, Tozzi AE, Calcaterra V, Longo D, Krzystofiak A, et al. Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Italian J Pediatr 2014;40:57. http://dx.doi.org/10.1186/1824-7288-40-57.
56. Dangond F, Engle E, Yessayan L, Sawyer MH. Pre-eruptive varicella cerebellitis confirmed by PCR. Pediatr Neurol 1993;9(6): 491-3
57. Gilden DH, Beinlich BR, Rubinstien EM, Stommel E, Swenson R, Rubinstein D, et al. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 1994;44(10):1818-23
58. Nakano T, Awaki E, Araga S, Takai H, Inoue K, Takahashi K. Recurrent herpes zoster myelitis treated with human interferon alpha: a case report. Acta Neurol Scand 1992;85(5): 372-5
59. Devinsky O, Cho ES, Petito CK, Price RW. Herpes zoster myelitis. Brain 1991;114(Pt 3):1181-96
60. Hung CH, Chang KH, Kuo HC, Huang CC, Liao MF, Tsai YT, et al. Features of varicella zoster virus myelitis and dependence on immune status. J Neurol Sci 2012;318(1e2):19-24 http://dx.doi.org/10.1016/j.jns.2012.04.017.
61. Askalan R, Laughlin S, Mayank S, Chan A, MacGregor D, Andrew M, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001;32(6):1257-62
62. Thomas SL, Minassian C, Ganesan V, Langan SM, Smeeth L. Chickenpox and risk of stroke: a self-controlled case series analysis. Clin Infect Dis 2014;58(1):61-8 http://dx.doi.org/10.1093/cid/cit659.
63. de Veber G, Roach ES, Riela AR, Wiznitzer M. Stroke in children: recognition, treatment, and future directions. Semin Pediatr Neurol 2000;7(4):309-17
64. Sebire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999;45(5):679-80
65. Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 2009;40(11):3443-8 http://dx.doi.org/10.1161/STROKEAHA.109.562017.
66. Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology 2010;74(10):792-7 http://dx.doi.org/10.1212/WNL.0b013e3181d31e5c.
67. Breuer J, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology 2014;82(3):206-12 http://dx.doi.org/10.1212/WNL.0000000000000038.
68. Hilt DC, Buchholz D, Krumholz A, Weiss H, Wolinsky JS. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 1983;14(5):543-53 http://dx.doi.org/10.1002/ana.410140509.
69. Fukumoto S, Kinjo M, Hokamura K, Tanaka K. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke 1986;17(5):1024-8
70. Amlie-Lefond C, Kleinschmidt-DeMasters BK, Mahalingam R, Davis LE, Gilden DH. The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol 1995;37(6):784-90
71. Ryder JW, Croen K, Kleinschmidt-DeMasters BK, Ostrove JM, Straus SE, Cohn DL. Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS. Ann Neurol 1986;19(2):182-8 http://dx.doi.org/10.1002/ana.410190212.
72. Gilden DH, Lipton HL, Wolf JS, Akenbrandt W, Smith JE, Mahalingam R, et al. Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med 2002; 347(19):1500-3 http://dx.doi.org/10.1056/NEJMoa020841.
73. Hall S, Carlin L, Roach ES, McLean Jr WT. Herpes zoster and central retinal artery occlusion. Ann Neurol 1983;13(2): 217-8 http://dx.doi.org/10.1002/ana.410130225.
74. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009;8(8):731-40 http://dx.doi.org/10.1016/S1474-4422(09)70134-6.
75. Teodoro T, Nagel MA, Geraldes R, White T, Mahalingam R, Batista P, et al. Biopsy-negative, varicella zoster virus (VZV)-positive giant cell arteritis, zoster, VZV encephalitis and ischemic optic neuropathy, all in one. J Neurol Sci 2014;343(1e2):195-7 http://dx.doi.org/10.1016/j.jns.2014.05.035.
76. Elble RJ. Intracerebral hemorrhage with herpes zoster ophthalmicus. Ann Neurol 1983;14(5):591-2 http://dx.doi.org/10.1002/ana.410140517.
77. Jain R, Deveikis J, Hickenbottom S, Mukherji SK. Varicellazoster vasculitis presenting with intracranial hemorrhage. AJNR Am J Neuroradiol 2003;24(5):971-4
78. Arrowsmith JB, Kennedy DL, Kuritsky JN, Faich GA. National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985. Pediatrics 1987;79(6):858-63
79. Braverman DL, Ku A, Nagler W. Herpes zoster polyradiculopathy. Arch Phys Med Rehabil 1997;78(8):880-2
80. Laurenti L, Garzia M, Sabatelli M, Piccioni P, Sora F, Leone G. Guillain-Barre' syndrome following varicella zoster reactivation in chronic lymphocytic leukemia treated with fludarabine. Haematologica 2002;87(11):ECR33.
81. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001;125(6):770-80
82. Rostad SW, Olson K, McDougall J, Shaw CM, Alvord Jr EC. Transsynaptic spread of varicella zoster virus through the visual system: a mechanism of viral dissemination in the central nervous system. Hum Pathol 1989;20(2):174-9
83. Arvin AM. Varicella-zoster virus: overview and clinical manifestations. Semin Dermatol 1996;15(2 Suppl 1):4-7
84. Mayberg M, Langer RS, Zervas NT, Moskowitz MA. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 1981; 213(4504):228-30
85. Horien C, Grose C. Neurovirulence of varicella and the live attenuated varicella vaccine virus. Semin Pediatr Neurol 2012;19(3):124-9 http://dx.doi.org/10.1016/j.spen.2012.02.006.
86. Horten B, Price RW, Jimenez D. Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann Neurol 1981;9(3):251-66 http://dx.doi.org/10.1002/ana.410090308.
87. Gilden DH. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci 2002;195(2):99-101
88. Miyazaki Y, Riku Y, Goto Y, Mano K, Yoshida M, Hashizume Y. VZV vasculopathy associated with myelo-radiculogangliomeningo-encephalitis: an autopsy case of an immunocompetent 66-year-old male. J Neurol Sci 2008;275(1e2):42-5 http://dx.doi.org/10.1016/j.jns.2008.07.019.
89. Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology 1996;47(6): 1441-6
90. Melanson M, Chalk C, Georgevich L, Fett K, Lapierre Y, Duong H, et al. Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology 1996;47(2):569-70
91. Doyle PW, Gibson G, Dolman CL. Herpes zoster ophthalmicus with contralateral hemiplegia: identification of cause. Ann Neurol 1983;14(1):84-5 http://dx.doi.org/10.1002/ana.410140115.
92. Eidelberg D, Sotrel A, Horoupian DS, Neumann PE, Pumarola-Sune T, Price RW. Thrombotic cerebral vasculopathy associated with herpes zoster. Ann Neurol 1986;19(1):7-14 http://dx.doi.org/10.1002/ana.410190103.
93. Nagel MA, Traktinskiy I, Azarkh Y, Kleinschmidt-DeMasters B, Hedley-Whyte T, Russman A, et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 2011;77(4):364-70 http://dx.doi.org/10.1212/WNL.0b013e3182267bfa.
94. Takashima S, Becker LE. Neuropathology of fatal varicella. Arch Pathol Lab Med 1979;103(5):209-13
95. Morgello S, Block GA, Price RW, Petito CK. Varicella-zoster virus leukoencephalitis and cerebral vasculopathy. Arch Pathol Lab Med 1988;112(2):173-7
96. Gray F, Mohr M, Rozenberg F, Belec L, Lescs MC, Dournon E, et al. Varicella-zoster virus encephalitis in acquired immunodeficiency syndrome: report of four cases. Neuropathol Appl Neurobiol 1992;18(5):502-14
97. Jemsek J, Greenberg SB, Taber L, Harvey D, Gershon A, Couch RB. Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) 1983;62(2):81-97
98. Puchhammer-Stockl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C. Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol 1991;29(7):1513-6
99. Barnes DW, Whitley RJ. CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy. Neurol Clin 1986;4(1):265-83
100. Wagner HJ, Seidel A, Grande-Nagel I, Kruse K, Sperner J. Preeruptive varicella encephalitis: case report and review of the literature. Eur J Pediatr 1998;157(10):814-5
101. Schadlich HJ, Nekic M, Jeske J, Karbe H. Intrathecal humoral immune reaction in zoster infections. J Neurol Sci 1991; 103(1):101-4
102. Tavazzi E, Minoli L, Ferrante P, Scagnelli P, Del Bue S, Romani A, et al. Varicella zoster virus meningo-encephalomyelitis in an immunocompetent patient. Neurol Sci 2008; 29(4):279-83 http://dx.doi.org/10.1007/s10072-008-0982-6.
103. Haanpaa M, Dastidar P, Weinberg A, Levin M, Miettinen A, Lapinlampi A, et al. CSF and MRI findings in patients with acute herpes zoster. Neurology 1998;51(5):1405-11
104. Tien RD, Felsberg GJ, Osumi AK. Herpesvirus infections of the CNS: MR findings. AJR Am J Roentgenol 1993;161(1):167-76
105. Moustafa RR, Baron JC. Clinical review: imaging in ischaemic strokeeimplications for acute management. Crit Care 2007; 11(5):227. http://dx.doi.org/10.1186/cc5973.
106. Eleftheriou D, Cox T, Saunders D, Klein NJ, Brogan PA, Ganesan V. Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography. Dev Med Child Neurol 2010;52(9): 863-7 http://dx.doi.org/10.1111/j.1469-8749.2009.03591.x.
107. Salvarani C, Brown Jr RD, Calamia KT, Christianson TJ, Weigand SD, Miller DV, et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007;62(5): 442-51 http://dx.doi.org/10.1002/ana.21226.
108. Cheng-Ching E, Jones S, Hui FK, Man S, Gilden D, Bhimraj A, et al. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci 2015;351(1e2):168-73 http://dx.doi.org/10.1016/j.jns.2015.02.017.
109. Russman AN, Lederman RJ, Calabrese LH, Embi PJ, Forghani B, Gilden DH. Multifocal varicella-zoster virus vasculopathy without rash. Arch Neurol 2003;60(11):1607-9 http://dx.doi.org/10.1001/archneur.60.11.1607.
110. Salvarani C, Brown Jr RD, Calamia KT, Christianson TJ, Huston 3rd J, Meschia JF, et al. Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels. Medicine (Baltimore) 2008;87(5):264-71 http://dx.doi.org/10.1097/MD.0b013e31818896-1
111. Osumi A, Tien RD. MR findings in a patient with Ramsay-Hunt syndrome. J Comput Assist Tomogr 1990;14(6):991-3
112. Gregoire SM, van Pesch V, Goffette S, Peeters A, Sindic CJ. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicellazoster virus infection of the nervous system. J Neurol Neurosurg Psychiatr 2006;77(8):938-42
113. Rottenstreich A, Oz ZK, Oren I. Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection. Diagn Microbiol Infect Dis 2014;79(2):174-7 http://dx.doi.org/10.1016/j.diagmicrobio.2014.02.015.
114. Schloss L, Falk KI, Skoog E, Brytting M, Linde A, Aurelius E. Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real-time PCR in patients with herpes simplex encephalitis. J Med Virol 2009;81(8): 1432-7 http://dx.doi.org/10.1002/jmv.21563.
115. Yamakawa K, Hamada M, Takeda T. Different real-time PCR assays could lead to a different result of detection of varicella-zoster virus in facial palsy. J Virol Methods 2007; 139(2):227-9 http://dx.doi.org/10.1016/j.jviromet.2006.10.008.
116. Furuta Y, Ohtani F, Aizawa H, Fukuda S, Kawabata H, Bergstrom T. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J 2005;24(2):97-101
117. Quinlivan ML, Ayres KL, Kelly PJ, Parker SP, Scott FT, Johnson RW, et al. Persistence of varicella-zoster virus viraemia in patients with herpes zoster. J Clin Virol 2011;50(2): 130-5 http://dx.doi.org/10.1016/j.jcv.2010.10.014.
118. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991;37(7): 1153-60
119. Studahl M, Bergstrom T, Hagberg L. Acute viral encephalitis in adultsea prospective study. Scand J Infect Dis 1998;30(3): 215-20
120. Vandvik B, Skoldenberg B, Forsgren M, Stiernstedt G, Jeansson S, Norrby E. Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis. J Neurol 1985;231(6):307-12
121. Grahn A, Studahl M, Nilsson S, Thomsson E, Backstrom M, Bergstrom T. Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without crossreaction to herpes simplex virus 1. Clin Vaccine Immunol 2011;18(8):1336-42 http://dx.doi.org/10.1128/CVI.05061-11.
122. Hellden A, Lycke J, Vander T, Svensson JO, Odar-Cederlof I, Stahle L. The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment. J Antimicrob Chemother 2006;57(5):945-9 http://dx.doi.org/10.1093/jac/dkl067.
123. Wood MJ, Shukla S, Fiddian AP, Crooks RJ. Treatment of acute herpes zoster: effect of early ( <48 h) versus late (48e72 h) therapy with acyclovir and valaciclovir on prolonged pain. J Infect Dis 1998;178(Suppl 1):S81-4
124. Whitley RJ, Blum MR, Barton N, de Miranda P. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Am J Med 1982;73(1A):165-71
125. Lycke J, Malmestrom C, Stahle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrobial Agents Chemother 2003;47(8):2438-41
126. Acosta EP, Fletcher CV. Valacyclovir. Ann Pharmacother 1997; 31(2):185-91
127. Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993; 54(6):595-605
128. Brink AA, van Gelder M, Wolffs PF, Bruggeman CA, van Loo IH. Compartmentalization of acyclovir-resistant varicella zoster virus: implications for sampling in molecular diagnostics. Clin Infect Dis 2011;52(8):982-7 http://dx.doi.org/10.1093/cid/cir079.
129. Biron KK, Fyfe JA, Noblin JE, Elion GB. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus. Am J Med 1982;73(1A):383-6
130. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2(7892):1288-90
131. Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, et al. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis 2008;197(Suppl 2): S170-7 http://dx.doi.org/10.1086/522161.
132. Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008;197(Suppl 2):S165-9 http://dx.doi.org/10.1086/522125.
133. Jean-Philippe P, Freedman A, Chang MW, Steinberg SP, Gershon AA, LaRussa PS, et al. Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction. Pediatrics 2007;120(5):e1345-1349 http://dx.doi.org/10.1542/peds.2004-1681.
134. Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009;28(11): 954-9 http://dx.doi.org/10.1097/INF.0b013e3181a90b16.
135. Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ. Review: the neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol 2011;37(5):441-63 http://dx.doi.org/10.1111/j.1365-2990.2011.01167.x.
136. Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, et al. Steering Committee and Investigators Group. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis 2012;55(10):1320-8 http://dx.doi.org/10.1093/cid/cis638.